差價合約是複雜的工具，並且由於槓桿作用而具有快速虧損的高風險。 84% 的散戶投資者賬戶在與該提供商交易差價合約時虧損。您應該考慮自己是否了解差價合約的運作方式，以及您是否有能力承擔損失資金的高風險。
Capital Com Australia Pty Ltd 澳大利亞（受 ASIC 監管） Capital Com UK Limited 由金融行為監管局 (FCA) 授權和監管 Capital Com SV Investments Limited 塞浦路斯/歐盟（受 CYSEC 監管） Сlosed Joint Stock Company «FinTech Solutions» （受 NBRB 監管） Smart Forex Broker LLC Capital Com Stock and CFD Investing Ltd 塞舌爾（受 FSA 監管） Capital Com Online Investments Ltd (Regulated by SCB) 我們的全球辦事處

掃碼下載 iOS 和安卓 APP

English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文
Also you can contact us: call +44 2030978888 support@capital.com

交易 Quince Therapeuticks Inc - QNCX CFD

1.4187
0%
  • 概括
  • 曆史數據
  • 活動
  • 收入報表
  • 資産負債表
  • 現金流
  • 所有權
交易條件
價差 0.0326
多頭倉位隔夜費用

Long position overnight fee

Margin. Your investment $1,000.00
隔夜費用 -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
來自槓桿的資金 ~ $4,000.00
前往平台
-0.024068%
空頭倉位隔夜費用

Short position overnight fee

Margin. Your investment $1,000.00
隔夜費用 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
來自槓桿的資金 ~ $4,000.00
前往平台
0.001846%
隔夜費時間 21:00 (UTC)
最小成交量 1
貨幣 USD
保證金 20%
股票交易 United States of America
交易委員會 0%

*Information provided by Capital.com

關鍵數據
前收盤價* 1.4187
開盤價* 1.3987
1 年變化* -76.88%
日範圍* 1.3887 - 1.4387
52 周範圍 0.54-6.80
平均交易量（10 天） 214.44K
平均交易量（3 個月） 28.49M
市值 30.53M
市盈率 -100.00K
流通股 36.28M
收入 N/A
EPS -1.61
股息（收益率 %） N/A
貝塔 1.27
下一個財報發布日期 N/A

所有數據都是由Refinitiv提供的， 除了標有星號的數據， 這是*由 Capital.com 提供的數據

  • 上週
  • 上個月
  • 去年
  • 過去兩年
  • 最大
  • 每日
  • 每週
  • 每月
日期 關閉 更改 變化 (%) 打開 高 低
Mar 21, 2023 1.4187 0.0000 0.00% 1.4187 1.5186 1.3388
Mar 20, 2023 0.8196 0.0004 0.05% 0.8192 0.8360 0.7892
Mar 17, 2023 0.8188 -0.0171 -2.05% 0.8359 0.8359 0.7848
Mar 16, 2023 0.8193 -0.0066 -0.80% 0.8259 0.8557 0.7919
Mar 15, 2023 0.8410 -0.0382 -4.34% 0.8792 0.8792 0.8155
Mar 14, 2023 0.8716 -0.0339 -3.74% 0.9055 0.9155 0.8691
Mar 13, 2023 0.8791 -0.0663 -7.01% 0.9454 0.9454 0.8656
Mar 10, 2023 0.9237 -0.0326 -3.41% 0.9563 0.9752 0.9237
Mar 9, 2023 0.9743 -0.0247 -2.47% 0.9990 1.0490 0.9643
Mar 8, 2023 0.9832 0.0080 0.82% 0.9752 0.9950 0.9393
Mar 7, 2023 0.9591 0.0079 0.83% 0.9512 0.9784 0.9491
Mar 6, 2023 0.9667 0.0023 0.24% 0.9644 0.9868 0.9433
Mar 3, 2023 0.9738 -0.0114 -1.16% 0.9852 0.9991 0.9695
Mar 2, 2023 0.9858 0.0404 4.27% 0.9454 0.9988 0.9392
Mar 1, 2023 0.9482 0.0228 2.46% 0.9254 0.9800 0.9118
Feb 28, 2023 0.9221 0.0066 0.72% 0.9155 0.9454 0.8908
Feb 27, 2023 0.9127 -0.0376 -3.96% 0.9503 0.9503 0.8745
Feb 24, 2023 0.9368 -0.0622 -6.23% 0.9990 0.9990 0.9208
Feb 23, 2023 0.9832 -0.0118 -1.19% 0.9950 1.0590 0.9803
Feb 22, 2023 1.0090 0.0103 1.03% 0.9987 1.0490 0.9537

Quince Therapeuticks Inc Events

时间（协调世界时） (UTC) 国家 事件
No events scheduled
查看所有活动
  • 年度
  • 每季度
2021 2020 2019 2018 2017
總收入 0 0 0 0 0
總營業費用 90.318 78.893 39.168 12.119 10.37
銷售/一般/行政費用，總計 29.523 17.586 8.954 2.034 1.271
研究與開發 60.795 61.307 30.214 10.085 9.099
營業收入 -90.318 -78.893 -39.168 -12.119 -10.37
利息收入（費用），非經營淨值 0.62 2.044 2.188 -0.357 -1.865
稅前淨收入 -89.945 -76.849 -36.98 -12.476 -12.235
稅後淨收入 -89.945 -76.849 -36.98 -12.476 -12.235
未計算非常項目前的淨收益 -89.945 -76.849 -36.98 -12.476 -12.235
非常規項目總計 0
淨收入 -89.945 -76.849 -36.98 -12.476 -12.235
普通股股東可獲收益 (不含非經常性項目) -89.945 -76.849 -36.98 -12.476 -12.235
普通股股東可獲收益 (含非經常性項目) -89.945 -76.849 -36.98 -12.476 -12.235
攤薄淨收入 -89.945 -76.849 -36.98 -12.476 -12.235
攤薄後加權平均股 29.7185 29.1762 19.0319 26.0133 26.0133
扣除特別項目的每股攤薄盈利 -3.02657 -2.63396 -1.94305 -0.4796 -0.47034
Dividends per Share - Common Stock Primary Issue 0 0
每股正常攤薄盈利 -3.02657 -2.63396 -1.94305 -0.4796 -0.47034
其他，淨值 -0.247
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
總收入 0 0 0 0 0
總營業費用 21.863 23.544 21.677 21.783 23.313
銷售/一般/行政費用，總計 9.106 8.331 7.639 7.064 6.489
研究與開發 12.757 15.213 14.038 14.719 16.824
營業收入 -21.863 -23.544 -21.677 -21.783 -23.313
利息收入（費用），非經營淨值 0.072 0.105 0.128 0.16 0.227
稅前淨收入 -21.641 -23.399 -21.706 -21.754 -23.086
稅後淨收入 -21.641 -23.399 -21.706 -21.754 -23.086
未計算非常項目前的淨收益 -21.641 -23.399 -21.706 -21.754 -23.086
淨收入 -21.641 -23.399 -21.706 -21.754 -23.086
普通股股東可獲收益 (不含非經常性項目) -21.641 -23.399 -21.706 -21.754 -23.086
普通股股東可獲收益 (含非經常性項目) -21.641 -23.399 -21.706 -21.754 -23.086
攤薄淨收入 -21.641 -23.399 -21.706 -21.754 -23.086
攤薄後加權平均股 30.1345 29.962 29.7674 29.5874 29.5549
扣除特別項目的每股攤薄盈利 -0.71815 -0.78095 -0.72919 -0.73525 -0.78112
Dividends per Share - Common Stock Primary Issue 0 0 0 0
每股正常攤薄盈利 -0.71815 -0.78095 -0.72919 -0.73525 -0.78112
其他，淨值 0.15 0.04 -0.157 -0.131
  • 年度
  • 每季度
2021 2020 2019 2018 2017
流動資産總額 111.673 137.862 106.056 72.584 7.537
現金和短期投資 106.802 133.82 99.864 71.716 7.343
Cash 40.27 35.69 4.074 11.259 7.343
現金等價物 15.954 16.151 46.155 11.815 0
短期投資 50.578 81.979 49.635 48.642 0
Prepaid Expenses 3.376 3.348 5.504 0.766 0.141
Other Current Assets, Total 1.495 0.694 0.688 0.102 0.053
Total Assets 133.228 189.466 124.37 72.877 7.718
Property/Plant/Equipment, Total - Net 1.428 1.101 1.334 0.283 0.122
Property/Plant/Equipment, Total - Gross 2.387 1.716 1.617 0.378 0.166
Accumulated Depreciation, Total -0.959 -0.615 -0.283 -0.095 -0.044
Other Long Term Assets, Total 0.194 0.039 0.217 0.01 0.059
Total Current Liabilities 14.222 16.996 8.892 1.457 1.763
Accounts Payable 4.911 3.555 3.075 0.495 0.517
Accrued Expenses 9.311 13.441 5.817 0.962 1.246
Notes Payable/Short Term Debt 0 0 0 0 0
Total Liabilities 14.642 17.204 8.892 1.457 10.82
Total Long Term Debt 0 0 0 0 7.171
Long Term Debt 0 7.171
Other Liabilities, Total 0.42 0.208 0 1.886
Total Equity 118.586 172.262 115.478 71.42 -3.102
Redeemable Preferred Stock 0 104.046 17.178
Common Stock 0.03 0.029 0.027 0.009 0.009
Additional Paid-In Capital 355.234 318.574 185.196 0.239 0.06
Retained Earnings (Accumulated Deficit) -236.599 -146.654 -69.805 -32.825 -20.349
Other Equity, Total -0.079 0.313 0.06 -0.049 0
Total Liabilities & Shareholders’ Equity 133.228 189.466 124.37 72.877 7.718
Total Common Shares Outstanding 30.0744 29.5432 26.8694 26.0133 26.0133
Long Term Investments 19.933 50.464 16.763
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
流動資産總額 96.353 111.673 119.427 135.843 149.885
現金和短期投資 91.524 106.802 114.412 129.95 147.035
Cash 27.403 40.27 8.357 5.744 24.569
現金等價物 32.361 15.954 36.6 47.049 38.246
短期投資 31.76 50.578 69.455 77.157 84.22
Prepaid Expenses 2.784 3.376 4.52 5.455 2.293
Other Current Assets, Total 2.045 1.495 0.495 0.438 0.557
Total Assets 116.13 133.228 147.416 161.39 174.522
Property/Plant/Equipment, Total - Net 0.573 1.428 1.655 1.886 0.878
Property/Plant/Equipment, Total - Gross 1.569 2.387 2.53 2.674 1.579
Accumulated Depreciation, Total -0.996 -0.959 -0.875 -0.788 -0.701
Long Term Investments 19.175 19.933 26.141 23.516 23.72
Other Long Term Assets, Total 0.029 0.194 0.193 0.145 0.039
Total Current Liabilities 9.71 14.222 14.154 18.537 17.867
Accounts Payable 3.731 4.911 2.88 7.193 2.845
Accrued Expenses 5.979 9.311 11.274 11.344 15.022
Notes Payable/Short Term Debt 0 0 0 0 0
Total Liabilities 9.75 14.642 14.764 19.31 18.038
Total Long Term Debt 0 0 0 0 0
Other Liabilities, Total 0.04 0.42 0.61 0.773 0.171
Total Equity 106.38 118.586 132.652 142.08 156.484
Common Stock 0.03 0.03 0.03 0.03 0.029
Additional Paid-In Capital 365.096 355.234 345.751 333.427 326.006
Retained Earnings (Accumulated Deficit) -258.24 -236.599 -213.2 -191.494 -169.74
Other Equity, Total -0.506 -0.079 0.071 0.117 0.189
Total Liabilities & Shareholders’ Equity 116.13 133.228 147.416 161.39 174.522
Total Common Shares Outstanding 30.1496 30.0744 29.8673 29.6558 29.5759
  • 年度
  • 每季度
2021 2020 2019 2018 2017
淨收入/起跑線 -89.945 -76.849 -36.98 -12.476 -12.235
經營活動産生的現金 -62.932 -50.818 -33.277 -11.695 -9.827
經營活動産生的現金 0.344 0.332 0.188 0.051 0.045
非現金物品 30.93 15.472 1.611 1.12 1.903
已付現金利息 0.001 0.001
營運資金的變化 -4.261 10.227 1.904 -0.39 0.46
投資活動産生的現金 58.952 -52.431 -17.747 -46.754 -0.077
資本支出 -0.18 -0.052 -0.055 -0.212 -0.077
其他投資現金流量項目，總計 59.132 -52.379 -17.692 -46.542 0
融資活動産生的現金 6.808 118.876 77.366 75.928 7.75
股票的發行（報廢），淨額 6.808 118.91 77.925 75.678 0
債務的發行（退還），淨額 0 -0.034 -0.559 0.25 7.75
現金淨變化 2.883 15.627 26.342 17.479 -2.154
外彙效應 0.055
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line -21.641 -89.945 -66.546 -44.84 -23.086
Cash From Operating Activities -16.091 -62.932 -48.514 -31.172 -13.61
Cash From Operating Activities 0.038 0.344 0.26 0.173 0.086
Non-Cash Items 9.375 30.93 22.238 14.371 7.285
Changes in Working Capital -3.863 -4.261 -4.466 -0.876 2.105
Cash From Investing Activities 13.413 58.952 38.033 37.267 31.643
Capital Expenditures -0.005 -0.18 -0.136 -0.136 -0.037
Other Investing Cash Flow Items, Total 13.418 59.132 38.169 37.403 31.68
Cash From Financing Activities 0.622 6.808 5.818 1.113 0.441
Issuance (Retirement) of Stock, Net 0.622 6.808 5.818 1.113 0.441
Net Change in Cash -2.16 2.883 -4.634 7.208 18.474
Issuance (Retirement) of Debt, Net 0 0 0
Foreign Exchange Effects -0.104 0.055 0.029
投資者名稱 投資者類型 流通股百分比 持有股份 股份變動 持有日期 換手率
Lamond (David A.) Individual Investor 10.1543 3683658 1634720 2022-01-31
Dominy (Stephen S) Individual Investor 3.9631 1437674 763 2022-01-31
Lynch (Casey C) Individual Investor 3.2544 1180580 -120000 2022-01-31
EPIQ Capital Group, LLC Investment Advisor 2.9115 1056191 -1000478 2022-12-31 LOW
Two Sigma Investments, LP Hedge Fund 2.4701 896084 -61145 2022-12-31 HIGH
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.3524 853391 -18615 2022-12-31 LOW
Pfizer Inc Corporation 1.6539 600000 -1456377 2021-12-31 MED
Millennium Management LLC Hedge Fund 1.6424 595801 137810 2022-12-31 HIGH
Low (Philip S) Individual Investor 1.2551 455309 455309 2022-05-19
BlackRock Institutional Trust Company, N.A. Investment Advisor 0.9169 332627 -165208 2022-12-31 LOW
Thye (Dirk) Individual Investor 0.7744 280911 280911 2022-05-19
Lowe (Christopher P) Individual Investor 0.7305 265000 175000 2022-03-03 LOW
Federated Hermes MDTA LLC Investment Advisor/Hedge Fund 0.6904 250458 -264583 2022-12-31 HIGH
Smith (Karen L) Individual Investor 0.5367 194690 194690 2022-05-19 LOW
Alphabet, Inc. Venture Capital 0.5213 189122 0 2022-12-31 LOW
Renaissance Technologies LLC Hedge Fund 0.4248 154100 -180125 2022-12-31 HIGH
Acadian Asset Management LLC Investment Advisor/Hedge Fund 0.4239 153788 0 2022-12-31 MED
Holsinger (Leslie) Individual Investor 0.3985 144580 -10920 2022-06-06
Detke (Michael J) Individual Investor 0.3859 140000 140000 2022-03-03
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.3779 137086 -9128 2022-12-31 LOW

為什麼選擇Capital.com？我們用表現來證明自己。

Capital.com Group

500K+

貿易商

92K+

每月活躍客戶

$53M+

每月投資額

$30M+

每月提取

差價合約交易計算器

如果您在特定日期（選取一個日期）開立差價合約交易並在不同日期（選取一個日期）關閉交易，計算您的假設盈虧。

交易佣金
0
  • 1:1
槓桿
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
投資
交易規模（槓桿 x 投資）：
打開

關閉

做空 做多
過往表現並非未來業績的可靠指標
盈利/虧損
Industry: Biotechnology & Medical Research (NEC)

269 East Grand Ave
94080

收入報表

  • Annual
  • Quarterly

人們也觀看

Gold

1,969.99 Price
+1.510% 1D Chg, %
多頭倉位隔夜費用 -0.0086%
空頭倉位隔夜費用 0.0004%
隔夜費時間 21:00 (UTC)
價差 0.30

BTC/USD

27,283.55 Price
-2.830% 1D Chg, %
多頭倉位隔夜費用 -0.0616%
空頭倉位隔夜費用 0.0137%
隔夜費時間 21:00 (UTC)
價差 60.00

US100

12,567.80 Price
-1.370% 1D Chg, %
多頭倉位隔夜費用 -0.0241%
空頭倉位隔夜費用 0.0018%
隔夜費時間 21:00 (UTC)
價差 3.0

XRP/USD

0.42 Price
-13.760% 1D Chg, %
多頭倉位隔夜費用 -0.0753%
空頭倉位隔夜費用 0.0069%
隔夜費時間 21:00 (UTC)
價差 0.00346

還在尋找值得信賴的經紀商？

加入全球 500.000 多名交易者，選擇與 Capital.com 交易

1. 建立並驗證您的賬戶 2. 存入您的第一筆資金 3. 您已準備就緒。開始交易